Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Datadog, Inc. (DDOG) Receives ‘Buy’ Rating and $154.3 Price Target from CMB International on Strong Growth Potential

We recently compiled a list of the 10 AI News Making Waves Today. In this article, we are going to take a look at where Datadog, Inc. (NASDAQ:DDOG) stands against the other AI stocks that are making waves today.

Is the AGI bubble about to burst? According to Margaret Mitchell, chief ethics scientist at the AI startup Hugging Face, it is to some extent. The crux of the matter is that, while essential for building more advanced systems, high-quality, human-made training data is lacking. Additionally, minor improvements to AI technologies such as ChatGPT are failing to justify the enormous costs associated with building and operating new models. That said, Bloomberg reports that three of the leading AI companies are now witnessing diminishing returns from their costly efforts to build newer models of artificial intelligence products.

READ ALSO: 10 AI Headlines Making Waves Today and 15 AI News You Must Read Today

It is reported that the upcoming iteration of Google’s Gemini software is falling short of internal expectations. Likewise, Anthropic has also been experiencing delays in releasing its highly anticipated Claude model, 3.5 Opus. Moreover, OpenAI’s Orion is reportedly not meeting its desired performance expectations. Although market commentary may indicate otherwise, a Google DeepMind spokesperson has noted that the company is “pleased with the progress we’re seeing on Gemini and we’ll share more when we’re ready”. On the other hand, Bloomberg reports that companies such as OpenAI and Anthropic have declined to comment. In turn, Anthropic pointed out to a podcast featuring Chief Executive Officer Dario Amodei.

“People call them scaling laws. That’s a misnomer,” he said on the podcast. “They’re not laws of the universe. They’re empirical regularities. I am going to bet in favor of them continuing, but I’m not certain of that”.

According to Amodei, many factors may come in the way of reaching more powerful AI in the next few years, but companies who are optimistic about artificial intelligence will most likely find a way around them. As the race to develop more advanced AI continues, recent developments in the field highlight both the challenges and breakthroughs that are shaping its future.

Latest Events in AI

According to a report from Bloomberg, OpenAI is on its way to launch a new artificial intelligence agent codenamed “Operator”. The AI agent will be able to take actions on a person’s behalf, such as writing code or booking travel. The tool is reportedly released in January as a research preview.

In other news, a Google chatbot has seemingly responded in a non-sensical manner to a Grad student in a back-and-forth conversation they were having about aging adults. The grad student was seeking homework help when the chatbot responded in a threatening manner.  The response from the chatbot appeared disconnected from the context and lacked coherence, raising concerns about the current limitations of large language models (LLMs). While LLMs have made significant advancements, this incident underscores the need for further refinement in ensuring their reliability and accuracy in handling complex and nuanced topics.

“Large language models can sometimes respond with non-sensical responses, and this is an example of that. This response violated our policies and we’ve taken action to prevent similar outputs from occurring.”

– Google in a statement to CBS News

For this article, we selected AI stocks by going through news articles, stock analysis, and press releases. These stocks are also popular among hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A close-up of a laptop with a software engineer coding on the monitor.

Datadog, Inc. (NASDAQ:DDOG)

Market Capitalization: $42.34 billion

Datadog, Inc. (NASDAQ:DDOG) offers a SaaS-based cloud-based monitoring and analytics program with expertise in cloud computing and AI-powered cybersecurity products.

On November 14, CMB International Securities analyst Saiyi HE initiated Datadog, Inc. (NASDAQ:DDOG) with a “Buy” rating and a price target of $154.3. According to the analyst, several factors point toward the company’s strong market position and growth potential. For starters, it is poised to benefit from the ongoing cloud migration and digital transformation trends that are expected to continue driving significant growth in cloud-based technologies. In this regard, Datadog’s comprehensive observability program gives it an edge and meets the modern demands of hybrid cloud environments. The company’s impressive revenue growth projections and increase in large customers are a big plus point. To conclude, the price target rise is a reflection of confidence in the company’s ability to maintain its growth trajectory and capture market opportunities, especially with the increasing adoption of its AI-powered solutions.

Overall DDOG ranks 4th on our list of the AI stocks that are making waves today. While we acknowledge the potential of DDOG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than DDOG but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…